GO:0031948 positive regulation of glucocorticoid biosynthetic process: Hormone Synthesis Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031948 describes any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glucocorticoids [QuickGO definition].
• Glucocorticoid biosynthesis is positively regulated by multiple signaling inputs, including endogenous glucocorticoid signaling itself, which can shape CD8+ T cell differentiation and dysfunction in the tumor microenvironment.
• The bone marrow provides a protective niche that optimizes immunological memory during dietary restriction, a process linked to glucocorticoid regulation.
• Macrophage migration inhibitory factor (MIF) promotes glucocorticoid resistance in severe asthma, highlighting how positive regulation of glucocorticoid biosynthesis intersects with inflammatory disease.
• Glucocorticoids can elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation, revealing a role in cancer therapy response.
• Studying GO:0031948 requires integrated approaches such as CRISPR knockout, point mutation, knock-in, overexpression, and CRISPR library screening to dissect causal genes and pathways.
Description
Glucocorticoids are steroid hormones synthesized in the adrenal cortex that regulate diverse physiological processes, including metabolism, immune response, and stress adaptation. The Gene Ontology term GO:0031948, positive regulation of glucocorticoid biosynthetic process, captures the upstream signals and molecular events that enhance the production of these hormones. Understanding this process is critical because dysregulated glucocorticoid biosynthesis contributes to diseases ranging from autoimmune disorders to cancer [2, 6]. Recent studies have shown that endogenous glucocorticoid signaling regulates CD8+ T cell differentiation and the development of dysfunction in the tumor microenvironment, underscoring the importance of positive regulation in immune surveillance. Moreover, the bone marrow can protect and optimize immunological memory during dietary restriction, a phenomenon that involves glucocorticoid-dependent mechanisms. These findings highlight that positive regulation of glucocorticoid biosynthesis is not merely a metabolic endpoint but a dynamic process with broad physiological and pathological implications. Researchers studying this term need reliable models to identify the genes and pathways that activate glucocorticoid production. This article provides a research-grade overview of GO:0031948, including its definition, key genes, regulatory mechanisms, disease associations, and experimental strategies for investigation.
positive regulation of glucocorticoid biosynthetic process At A Glance
| GO ID | GO:0031948 |
|---|---|
| GO term | positive regulation of glucocorticoid biosynthetic process |
| Ontology | biological_process |
| Synonym | activation of glucocorticoid biosynthetic process; stimulation of glucocorticoid biosynthetic process; up regulation of glucocorticoid biosynthetic process; up-regulation of glucocorticoid biosynthetic process; upregulation of glucocorticoid biosynthetic process |
| Major function | Upregulation of the chemical reactions and pathways that produce glucocorticoids |
| Related process | Glucocorticoid biosynthetic process (GO:0006704) and its regulation |
| Biological context | Adrenal steroidogenesis, immune regulation, stress response, metabolic homeostasis |
| Research relevance | Target for understanding diseases such as asthma, cancer, and autoimmune disorders |
What Is GO:0031948?
GO:0031948, positive regulation of glucocorticoid biosynthetic process, is defined as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glucocorticoids. In other words, it encompasses all molecular events that upregulate the biosynthesis of glucocorticoid hormones, from signal transduction to enzymatic steps.
Why Is positive regulation of glucocorticoid biosynthetic process Important in Cell Biology?
Positive regulation of glucocorticoid biosynthesis is essential for maintaining systemic homeostasis and mounting appropriate stress and immune responses. Dysregulation of this process is implicated in a wide range of pathologies, including chronic inflammatory diseases, cancer, and metabolic disorders. For instance, macrophage migration inhibitory factor promotes glucocorticoid resistance in severe asthma, demonstrating how aberrant regulation can undermine therapy. Conversely, glucocorticoids can enhance clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation, suggesting that boosting glucocorticoid biosynthesis could improve treatment outcomes. Therefore, deciphering the mechanisms that positively regulate glucocorticoid production offers opportunities for therapeutic intervention.
• Regulates immune cell differentiation and function, including CD8+ T cells in the tumor microenvironment.
• Modulates immunological memory during dietary restriction via bone marrow niches.
• Contributes to glucocorticoid resistance in severe asthma through MIF.
• Enhances sensitivity of clear cell renal cell carcinoma to HIF-2α inhibitors.
• Impacts adiponectin expression in human adipocytes, linking to obesity and metabolic syndrome.
• Plays a role in age-related cardiac changes and glucocorticoid signaling in the aging heart.
• Involved in osteonecrosis of the femoral head through dopamine D1 receptor and ATF3/CHOP axis.
• Associated with idiopathic pulmonary fibrosis via SGK1-mediated macrophage reprogramming.
• Provides a target for CRISPR-based screens to identify novel regulators.
• Offers potential for therapeutic modulation in inflammatory and oncological diseases.
What Happens During positive regulation of glucocorticoid biosynthetic process?
Initiation of Steroidogenic Signaling
In simple terms: The process starts when signals tell the adrenal cells to make more glucocorticoids.
Positive regulation begins with extracellular signals such as adrenocorticotropic hormone (ACTH) or local factors that activate receptors on steroidogenic cells. These signals trigger intracellular cascades, including cAMP/PKA pathways, that ultimately increase the expression or activity of steroidogenic enzymes. Endogenous glucocorticoid signaling itself can feed back to modulate this process, as seen in CD8+ T cell differentiation within the tumor microenvironment. Additionally, dietary restriction can influence glucocorticoid regulation through bone marrow-mediated mechanisms that protect immunological memory.
Transcriptional Upregulation of Steroidogenic Enzymes
In simple terms: The cell increases the production of enzymes that build glucocorticoids.
Key steroidogenic enzymes such as CYP11B1, CYP21A2, and StAR are transcriptionally upregulated in response to positive regulatory signals. This upregulation ensures sufficient enzymatic capacity for glucocorticoid synthesis. Macrophage migration inhibitory factor (MIF) has been shown to promote glucocorticoid resistance in severe asthma, indicating that MIF can interfere with this transcriptional program. Conversely, glucocorticoids themselves can suppress H4K12 lactylation to enhance HIF-2α inhibitor sensitivity in clear cell renal cell carcinoma, suggesting a complex feedback loop.
Post-translational Modulation of Enzyme Activity
In simple terms: Enzymes can be chemically modified to work faster or slower.
Beyond transcription, positive regulation can occur through post-translational modifications that enhance the activity or stability of steroidogenic enzymes. For example, phosphorylation of StAR protein increases cholesterol transport into mitochondria, the rate-limiting step in steroidogenesis. SGK1 has been implicated in macrophage reprogramming and immune homeostasis, potentially influencing glucocorticoid production. Dopamine D1 receptor signaling protects against glucocorticoid-associated osteonecrosis through the ATF3/CHOP axis, indicating that G-protein coupled receptor pathways can modulate enzyme activity.
Integration with Systemic Physiology
In simple terms: The whole body coordinates to adjust glucocorticoid levels.
Positive regulation of glucocorticoid biosynthesis is integrated with systemic physiology, including the hypothalamic-pituitary-adrenal (HPA) axis, metabolic status, and immune signals. For instance, glucocorticoid signaling in the aging heart affects cardiac function and stress responses. Adiponectin expression in human adipocytes is regulated by glucocorticoids and adiposity, linking energy balance to glucocorticoid production. These systemic inputs ensure that glucocorticoid levels are appropriately elevated during stress or immune challenges.
Key Genes Involved in GO:0031948 positive regulation of glucocorticoid biosynthetic process
The following genes and proteins are key players in the positive regulation of glucocorticoid biosynthetic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SGK1 | Serum/glucocorticoid regulated kinase 1; modulates macrophage reprogramming and immune homeostasis | Implicated in idiopathic pulmonary fibrosis and glucocorticoid signaling |
| MIF | Macrophage migration inhibitory factor; promotes glucocorticoid resistance | Target in severe asthma and inflammatory diseases |
| ATF3 | Activating transcription factor 3; involved in stress responses and apoptosis | Protects against glucocorticoid-associated osteonecrosis |
| CHOP | C/EBP homologous protein; mediates ER stress-induced apoptosis | Part of ATF3/CHOP axis in osteonecrosis |
| HIF-2α | Hypoxia-inducible factor 2 alpha; regulates oxygen homeostasis | Glucocorticoids enhance sensitivity to HIF-2α inhibitors in ccRCC |
| StAR | Steroidogenic acute regulatory protein; transports cholesterol into mitochondria | Rate-limiting step in glucocorticoid biosynthesis |
| CYP11B1 | Cytochrome P450 family 11 subfamily B member 1; catalyzes final step of cortisol synthesis | Key enzyme in glucocorticoid production |
| CYP21A2 | Cytochrome P450 family 21 subfamily A member 2; involved in cortisol and aldosterone synthesis | Deficiency causes congenital adrenal hyperplasia |
| CYP17A1 | Cytochrome P450 family 17 subfamily A member 1; steroid 17-alpha-hydroxylase | Part of steroidogenic pathway |
| HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Catalyzes an early step in glucocorticoid synthesis |
| NR3C1 | Nuclear receptor subfamily 3 group C member 1; glucocorticoid receptor | Mediates feedback regulation of glucocorticoid biosynthesis |
| POMC | Proopiomelanocortin; precursor to ACTH | ACTH stimulates glucocorticoid production |
| MC2R | Melanocortin 2 receptor; ACTH receptor | Mediates ACTH signaling in adrenal cortex |
| ADCYAP1 | Adenylate cyclase activating polypeptide 1; regulates cAMP signaling | Modulates steroidogenesis |
| PRKACA | Protein kinase cAMP-activated catalytic subunit alpha | Phosphorylates targets to enhance steroidogenesis |
| NR4A1 | Nuclear receptor subfamily 4 group A member 1; transcription factor | Regulates steroidogenic gene expression |
| CREB1 | cAMP responsive element binding protein 1 | Transcription factor that upregulates steroidogenic enzymes |
| SGK1 | Serum/glucocorticoid regulated kinase 1 | Modulates ion transport and cell survival in response to glucocorticoids |
How Is positive regulation of glucocorticoid biosynthetic process Regulated?
Positive regulation of glucocorticoid biosynthesis is controlled by multiple signaling pathways. The HPA axis provides endocrine control via ACTH, which activates MC2R and cAMP/PKA signaling. Local factors such as MIF can promote glucocorticoid resistance, effectively dampening the positive regulation in inflammatory contexts. SGK1 is a downstream target of glucocorticoids and can feedback to modulate cellular responses. Additionally, metabolic signals from adipose tissue, such as adiponectin, influence glucocorticoid action. The bone marrow microenvironment can also regulate glucocorticoid production during dietary restriction, optimizing immunological memory.
positive regulation of glucocorticoid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MIF | Severe asthma, glucocorticoid resistance | MIF knockout mice or human airway epithelial cells with MIF overexpression |
| SGK1 | Idiopathic pulmonary fibrosis | SGK1 knockout or knock-in macrophages in bleomycin-induced fibrosis model |
| HIF-2α | Clear cell renal cell carcinoma | ccRCC cell lines with HIF-2α point mutations and glucocorticoid treatment |
| ATF3 | Osteonecrosis of the femoral head | ATF3 knockout osteoblasts treated with glucocorticoids |
| NR3C1 | Glucocorticoid resistance syndromes | CRISPR knock-in of NR3C1 mutations in adrenal cells |
Glucocorticoid Resistance in Severe Asthma
Macrophage migration inhibitory factor (MIF) promotes glucocorticoid resistance in neutrophilic inflammation in a murine model of severe asthma. This suggests that positive regulation of glucocorticoid biosynthesis may be impaired or overridden in severe asthma, leading to poor response to corticosteroid therapy. Targeting MIF or enhancing endogenous glucocorticoid production could restore sensitivity.
Cancer: Clear Cell Renal Cell Carcinoma
Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation. This indicates that positive regulation of glucocorticoid biosynthesis could be therapeutically exploited to improve responses to targeted therapies in ccRCC. Modulating this pathway may overcome resistance to HIF-2α inhibitors.
Idiopathic Pulmonary Fibrosis
SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3K27ac-mediated macrophage reprogramming and disturbing immune homeostasis. Since SGK1 is a glucocorticoid-regulated kinase, its dysregulation may impact glucocorticoid biosynthesis and contribute to fibrotic pathology. Understanding this link could reveal new targets for antifibrotic therapies.
Osteonecrosis of the Femoral Head
Dopamine D1 receptor contributes to glucocorticoid-associated osteonecrosis of the femoral head protection through the ATF3/CHOP axis to inhibit osteoblastic apoptosis. This highlights how glucocorticoid signaling intersects with bone homeostasis and suggests that positive regulation of glucocorticoid biosynthesis may influence osteonecrosis risk.
From positive regulation of glucocorticoid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate glucocorticoid biosynthesis? | CRISPR knockout of gene X in adrenal cell lines (e.g., H295R) followed by cortisol measurement |
| Does a specific point mutation in gene Y alter enzyme activity? | CRISPR point mutation knock-in in steroidogenic cells |
| Does overexpression of gene Z enhance glucocorticoid production? | CRISPR-mediated overexpression or lentiviral transduction in adrenal cells |
| What is the role of gene W in immune regulation via glucocorticoids? | Conditional knockout in mouse immune cells with glucocorticoid challenge |
| Can a tagged version of protein V reveal its localization during steroidogenesis? | Knock-in of fluorescent or epitope tag at endogenous locus |
| Which genes are essential for positive regulation? | Genome-wide CRISPR library screening in adrenal cells under ACTH stimulation |
How to Study the positive regulation of glucocorticoid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on glucocorticoid production | Identify novel positive regulators in adrenal cells |
| RNA-seq | Transcriptional changes in steroidogenic pathways | Compare stimulated vs. unstimulated cells |
| Proteomics | Protein abundance and modifications | Quantify steroidogenic enzymes and PTMs |
| ELISA | Cortisol or corticosterone levels | Measure glucocorticoid output in culture media |
| Live-cell imaging | Subcellular localization and dynamics | Track StAR or CYP11B1 trafficking |
| ChIP-seq | Transcription factor binding to steroidogenic gene promoters | Map CREB or NR4A1 binding sites |
| CRISPR activation (CRISPRa) | Gain-of-function effects on target genes | Overexpress candidate regulators |
| CRISPR interference (CRISPRi) | Knockdown of target genes | Assess dose-dependent effects on glucocorticoid synthesis |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes whose loss alters glucocorticoid production. Adrenal cell lines such as H295R are transduced with a lentiviral sgRNA library, selected, and then stimulated with ACTH or cAMP analogs. Cortisol levels in the medium are measured by ELISA, and sgRNA enrichment in high versus low producers is analyzed by next-generation sequencing. This approach has been used to uncover regulators of steroidogenesis.
RNA Sequencing and Transcriptomics
RNA-seq of adrenal cells or tissues under conditions that stimulate glucocorticoid biosynthesis reveals transcriptional changes in steroidogenic enzymes and regulatory factors. Comparing wild-type and knockout models can pinpoint pathways that are positively regulated. For example, SGK1-dependent macrophage reprogramming was dissected using transcriptomic profiling.
Proteomics and Post-translational Modification Analysis
Mass spectrometry-based proteomics can quantify steroidogenic enzymes and their post-translational modifications, such as phosphorylation, that enhance activity. This is particularly useful for understanding rapid, non-transcriptional positive regulation. Studies on H4K12 lactylation in ccRCC have employed proteomic approaches to link glucocorticoids to epigenetic changes.
Imaging and Live-cell Tracking
Fluorescent tagging of steroidogenic enzymes or cholesterol transporters allows real-time visualization of their localization and dynamics during glucocorticoid biosynthesis. Knock-in of GFP or HaloTag at endogenous loci enables tracking of protein trafficking to mitochondria, a key step in steroidogenesis. This can be combined with live-cell imaging to assess the impact of positive regulators.
How CRISPR Can Be Used to Study GO:0031948 positive regulation of glucocorticoid biosynthetic process
Knockout
CRISPR knockout of candidate genes in adrenal cell lines or mouse models can determine whether they are required for positive regulation of glucocorticoid biosynthesis. For example, knocking out MIF may reverse glucocorticoid resistance in asthma models. Similarly, SGK1 knockout can test its role in pulmonary fibrosis and macrophage reprogramming.
Point Mutation
Introducing specific point mutations via CRISPR can mimic human polymorphisms or disease-associated variants in genes like NR3C1 or CYP11B1. This helps assess how single amino acid changes affect enzyme activity or regulatory function. For instance, point mutations in HIF-2α can alter sensitivity to glucocorticoid-mediated suppression of H4K12 lactylation.
Knock-in
Knock-in of reporter tags (e.g., GFP, luciferase) or epitope tags at endogenous loci allows real-time monitoring of steroidogenic enzyme expression and localization. This is valuable for studying dynamic positive regulation in live cells. Tagged StAR or CYP11B1 can reveal trafficking to mitochondria under stimulatory conditions.
Overexpression
CRISPR-mediated overexpression (e.g., via CRISPRa) or lentiviral transduction can test whether increasing the level of a candidate gene enhances glucocorticoid biosynthesis. Overexpressing SGK1 or MIF may exacerbate or ameliorate disease phenotypes in models of fibrosis or asthma [1, 6]. This approach is useful for validating gain-of-function hypotheses.
How EDITGENE Supports positive regulation of glucocorticoid biosynthetic process Research
Researchers studying positive regulation of glucocorticoid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in enhancing glucocorticoid production. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of glucocorticoid biosynthetic process research.
Frequently Asked Questions About positive regulation of glucocorticoid biosynthetic process
What is GO:0031948?
GO:0031948 is the Gene Ontology term for positive regulation of glucocorticoid biosynthetic process, defined as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glucocorticoids.
What genes are involved in positive regulation of glucocorticoid biosynthetic process?
Key genes include SGK1, MIF, ATF3, CHOP, HIF-2α, StAR, CYP11B1, CYP21A2, NR3C1, and POMC, among others, as supported by published literature [1, 4, 6, 7].
How is glucocorticoid biosynthesis positively regulated?
It is positively regulated by signaling pathways such as ACTH/cAMP/PKA, which upregulate steroidogenic enzymes, and by local factors that modulate enzyme activity or expression [2, 3, 6].
What diseases are associated with dysregulated glucocorticoid biosynthesis?
Diseases include severe asthma, clear cell renal cell carcinoma, idiopathic pulmonary fibrosis, and osteonecrosis of the femoral head [1, 4, 6, 7].
How can CRISPR be used to study positive regulation of glucocorticoid biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of specific genes in enhancing glucocorticoid production [1, 6, 7].
What cell models are suitable for studying glucocorticoid biosynthesis?
Adrenal cell lines such as H295R are commonly used, along with primary adrenal cells and mouse models with conditional knockouts [1, 6].
What is the role of MIF in glucocorticoid regulation?
MIF promotes glucocorticoid resistance in severe asthma, indicating it can negatively impact positive regulation of glucocorticoid biosynthesis.
How do glucocorticoids affect cancer therapy?
Glucocorticoids can elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation.
What is the connection between SGK1 and glucocorticoid biosynthesis?
SGK1 is a glucocorticoid-regulated kinase that aggravates idiopathic pulmonary fibrosis by triggering macrophage reprogramming, linking it to glucocorticoid signaling.
What services does EDITGENE offer for studying GO:0031948?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services to study positive regulation of glucocorticoid biosynthetic process.
Conclusion
Positive regulation of glucocorticoid biosynthetic process (GO:0031948) is a critical biological process with far-reaching implications for immune function, metabolism, and disease. Understanding the genes and mechanisms that enhance glucocorticoid production can reveal new therapeutic targets for conditions such as asthma, cancer, and fibrosis. By leveraging advanced CRISPR technologies and bioinformatics, researchers can dissect this pathway with unprecedented precision. EDITGENE stands ready to support these efforts with tailored cell models and screening services.
References
- 1. Wu J et al.. 2024. SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis.. Int J Biol Sci 20(3):968-986 PMID: 38250161
- 2. Acharya N et al.. 2020. Endogenous Glucocorticoid Signaling Regulates CD8(+) T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment.. Immunity 53(3):658-671.e6 PMID: 32937153
- 3. Collins N et al.. 2019. The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction.. Cell 178(5):1088-1101.e15 PMID: 31442402
- 4. Zheng K et al.. 2025. Dopamine D1 Receptor Contributes to Glucocorticoid-Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis.. Adv Sci (Weinh) 12(33):e02276 PMID: 40583147
- 5. Cruz-Topete D et al.. 2020. Glucocorticoid Signaling and the Aging Heart.. Front Endocrinol (Lausanne) 11:347 PMID: 32528419
- 6. Allam VSRR et al.. 2023. Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma.. Thorax 78(7):661-673 PMID: 36344253
- 7. Zhang K et al.. 2026. Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation.. Signal Transduct Target Ther 11(1) PMID: 41922306
- 8. Degawa-Yamauchi M et al.. 2005. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha.. Obes Res 13(4):662-9 PMID: 15897474
